Home 2022 April

Monthly Archives: April 2022

News

Vanda Pharmaceuticals and AnaptysBio announce global license agreement for Generalized Pustular Psoriasis treatment

Vanda Pharmaceuticals and AnaptysBio have announced an exclusive, global license agreement for the development and commercialization of imsidolimab (IL-36R antagonist mAb), which has successfully...

Jabil acquires Pharmaceutics International, Inc.

Jabil has acquired of Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) specializing in early stage, clinical, and commercial volume aseptic filling,...

U.S. FDA approves Vertex’s JOURNAVX for adults with moderate-to-severe acute pain

The U.S. Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals' JOURNAVX (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the...